capastat
eli lilly and company (nz) limited - capreomycin 1 g - solution for injection - 1 g - active: capreomycin 1 g
capastat powder for injection vial
aspen pharmacare australia pty ltd - capreomycin, quantity: 1 g - injection, powder for - excipient ingredients: - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) capreomycin, which is to be used concomitantly with other appropriate antituberculosis agents, is indicated in pulmonary infections caused by capreomycin-susceptible strains of m.tuberculosis when the primary agents (isoniazid, rifampicin, ethambutol, aminosalicylic acid and streptomycin) have been ineffective or cannot be used because of toxicity or the presence of resistant tubercle bacilli. susceptibility studies should be performed to determine the presence of a capreomycin-susceptible strain of m.tuberculosis.
medpro capreomycin injection
strides pharma (sa) (pty) ltd - injection - see ingredients - each vial contains capreomycin sulfate equivalent to capreomycin 1,0 g
capastat 1g powder for solution for injection vials
king pharmaceuticals ltd - capreomycin sulfate - powder for solution for injection - 1gram
kapocin injection 1 g
macleods pharmaceuticals limited, india - capreomycin - injection - 1 g
capastat 1 g injection
pharmacare limited û woodmead - injection - see ingredients - each 10,0 ml vial contains capreomycin sulfate equivalent to capreomycin 1,0 g
atasorb-n (suspension)
eli lilly and company limited - capreomycin -
capastat withdrawn form 1 g/100ml
eli lilly and company limited - capreomycin sulfate - withdrawn form - 1 g/100ml
kapocin inj. inj
macleods - capreomycin - inj - 0.5g - inj.
kapocin inj. inj
macleods - capreomycin - inj - 0.75g - inj.